STELITANO, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 1.179
AS - Asia 997
EU - Europa 715
SA - Sud America 199
AF - Africa 72
OC - Oceania 9
Totale 3.171
Nazione #
US - Stati Uniti d'America 1.135
CN - Cina 329
SG - Singapore 244
IE - Irlanda 145
BR - Brasile 143
HK - Hong Kong 136
IT - Italia 135
RU - Federazione Russa 125
VN - Vietnam 115
DE - Germania 73
GB - Regno Unito 57
FR - Francia 55
ZA - Sudafrica 51
IN - India 50
FI - Finlandia 29
BD - Bangladesh 26
AT - Austria 20
AR - Argentina 19
MX - Messico 19
CA - Canada 17
JP - Giappone 16
ID - Indonesia 11
IQ - Iraq 11
NL - Olanda 11
PL - Polonia 11
SE - Svezia 11
ES - Italia 10
EG - Egitto 9
UA - Ucraina 9
AU - Australia 8
CO - Colombia 8
CL - Cile 7
TR - Turchia 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
EC - Ecuador 6
MA - Marocco 6
PH - Filippine 6
PK - Pakistan 6
LT - Lituania 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
KR - Corea 4
BO - Bolivia 3
CZ - Repubblica Ceca 3
JO - Giordania 3
TN - Tunisia 3
BE - Belgio 2
DO - Repubblica Dominicana 2
GR - Grecia 2
HN - Honduras 2
KW - Kuwait 2
KZ - Kazakistan 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UY - Uruguay 2
AZ - Azerbaigian 1
BJ - Benin 1
CR - Costa Rica 1
IL - Israele 1
IM - Isola di Man 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
MZ - Mozambico 1
NO - Norvegia 1
NP - Nepal 1
PG - Papua Nuova Guinea 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SI - Slovenia 1
TW - Taiwan 1
Totale 3.171
Città #
San Jose 183
Hong Kong 131
Singapore 126
Ashburn 125
Dublin 115
Dallas 92
Beijing 81
Chandler 71
Boardman 57
Ho Chi Minh City 46
Johannesburg 38
Los Angeles 38
Lauterbourg 37
Council Bluffs 35
Shanghai 34
Munich 32
New York 32
Pavia 30
Redondo Beach 24
Hanoi 23
Helsinki 21
Ann Arbor 20
Milan 20
Moscow 20
Santa Clara 18
São Paulo 16
Lawrence 15
Princeton 15
The Dalles 15
Vienna 15
Medford 14
Tokyo 14
Chicago 13
Orem 13
Nanjing 12
Shenyang 11
Menlo Park 9
Nuremberg 9
Warsaw 9
Cape Town 8
Chennai 8
Florence 8
Haiphong 8
Hyderabad 8
Montreal 8
Nanchang 8
Turku 8
Wilmington 8
Atlanta 7
Boston 7
Brooklyn 7
Corteolona 7
Dearborn 7
Denver 7
Dhaka 7
Stockholm 7
Washington 7
Buffalo 6
Cinisello Balsamo 6
Frankfurt am Main 6
Guangzhou 6
London 6
Mumbai 6
Seattle 6
Amsterdam 5
Changsha 5
Columbus 5
Da Nang 5
Fairfield 5
Falkenstein 5
Hangzhou 5
Mexico City 5
Shenzhen 5
Tashkent 5
Turin 5
Worcester Park 5
Brasília 4
Cagliari 4
Chongqing 4
Coventry 4
Curitiba 4
Delhi 4
Erbil 4
Istanbul 4
Jiaxing 4
Palermo 4
Poplar 4
Quito 4
Recife 4
Rio de Janeiro 4
San Genesio ed Uniti 4
Secaucus 4
Tianjin 4
Amman 3
Armidale 3
Brighton 3
Caracas 3
Charlotte 3
Cologne 3
Dubai 3
Totale 1.955
Nome #
Characterization of mycobacterial enzymes as targets for potential antitubercular compounds. 127
Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients? 121
From virulence factors to drug development: MbtI as an effective Mycobacterium tuberculosis target 119
Structural and Activity Relationships of 6-Sulfonyl-8-Nitrobenzothiazinones as Antitubercular Agents 116
CanB, a Druggable Cellular Target in Mycobacterium tuberculosis 110
Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents 109
Improve protection to prevent infections: application of reverse vaccinology against cystic fibrosis pathogens. 107
Targeting iron uptake pathway for the development of novel antitubercular drugs. 100
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex 99
Mycobacterium abscessus siderophores biosynthesis as a target to inhibit the iron uptake mechanism 95
Mycobacterium tuberculosis Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 Compound. 90
Multitargeting Compounds: A Promising Strategy to Overcome Multi-Drug Resistant Tuberculosis 89
Exploring the role of the heterocyclic moiety of 5-(4-nitrophenyl)-2-furoic acid, a promising inhibitor of MbtI from Mycobacterium tuberculosis. 86
Repurposing of FDA-Approved Drugs to Disrupt Iron Uptake in Mycobacterium abscessus: Targeting Salicylate Synthase as a Novel Approach 83
Multi-target antitubercular drugs: identification of novel dual MbtI and MptpB inhibitors. 83
Benzothiozinone derivatives with anti-tubercular Activity−Further side chain investigation 81
Moles of Molecules against Mycobacterium abscessus: A Review of Current Research 81
Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options 80
Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria. 79
Structural insights for the development of novel antituberculars targeting the iron uptake pathway. 76
Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand? 73
Shedding X-ray light on the role of magnesium in the activity of M. tuberculosis salicylate synthase (MbtI) for drug design 73
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme 72
Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents 72
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 71
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 71
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy 67
Artificial Intuition and accelerating the process of antimicrobial drug discovery 62
Phage therapy: an alternative approach to combating multi-drug-resistant bacterial infections in cystic fibrosis 62
Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent 62
A dual-target approach in anti-tuberculosis therapy: new MptpB/MbtI. 61
Chapter 28. Multi-target Compounds for Tuberculosis 60
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis MbtI and MPtpB 60
Synthesis, characterization, and biological evaluation of new derivatives targeting MbtI as antitubercular agents 59
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus 58
Investigating the inhibition mechanism and catalytic cycle of MbtI, the salicylate synthase from Mycobacterium tuberculosis. 58
Moles of Molecules against Mycobacterium abscessus: A Review of Current Research 58
Synthesis and assessment of the in vitro and ex vivo activity of salicylate synthase (Mbti) inhibitors as new candidates for the treatment of mycobacterial infections 47
Targeting the mycobactin biosynthesis pathway in M. tuberculosis: a step towards the improvement of the anti-virulence activity of MbtI inhibitors. 43
Structural and biochemical investigations into the binding mode of furan-based inhibitors of MbtI from M. tuberculosis. 37
Polymersomes as selective drug delivery carriers for innovative anti-TB agents. 36
Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity 32
Phagocyte-targeting polymersomes as intracellular delivery carriers for enzymatic inhibitors with antitubercular activity. 30
Uncovering insights into the biology of Mycobacterium tuberculosis using genetic tools 16
Advancing the antituberculosis activity of nitropicolinic acids and amides 12
Dual SYK-HDAC Inhibitor Elicits Striking Efficacy against Acute Myeloid Leukemia: Rational Design, Synthesis, and Biological Evaluation 1
Totale 3.284
Categoria #
all - tutte 14.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.159


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 0 0 2
2021/2022109 0 0 0 40 2 1 4 4 12 8 7 31
2022/2023283 18 29 11 10 14 20 0 21 141 1 15 3
2023/2024325 26 52 19 41 24 55 31 16 1 22 9 29
2024/2025763 37 55 20 12 31 21 65 52 205 41 73 151
2025/20261.664 145 89 186 197 208 71 291 107 141 124 71 34
Totale 3.284